CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 78.1% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English

Trade Mitsui Chemicals, Inc. - 4183 CFD

4411.4
2.4%
Market Trading Hours* (UTC) Opens on Monday at 01:00

Mon: 01:00 - 02:30 03:30 - 06:00

Tue - Thu: 00:00 - 02:30 03:30 - 06:00

  • Summary
  • Historical Data
  • Events
  • Income Statement
  • Balance Sheet
  • Cash Flow
Trading сonditions
Spread 27.2
Long position overnight fee

Long position overnight fee


Margin. Your investment $1,000.00
Overnight fee -0.011022 %
Charges from full value of position ($-2.09)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.011022%
Short position overnight fee

Short position overnight fee


Margin. Your investment $1,000.00
Overnight fee -0.011201 %
Charges from full value of position ($-2.13)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.011201%
Overnight fee time 21:00 (UTC)
Min traded quantity 1
Currency JPY
Margin 5%
Stock exchange Japan
Commission on trade 0%

*Information provided by Capital.com

Mitsui Chemicals Inc ESG Risk Ratings

High Medium Low Negligible

‘B’ score indicates good relative ESG performance and above average degree of transparency in reporting material ESG data publicly.

More ESG coverage

Key Stats
Prev. Close* 4520
Open* 4448.3
1-Year Change* 35.98%
Day's Range* 4396.4 - 4489.3
52 wk Range 2,908.00-4,493.00
Average Volume (10 days) 667.53K
Average Volume (3 months) 16.44M
Market Cap 868.45B
P/E Ratio 13.93
Shares Outstanding 190.14M
Revenue 1,752.12B
EPS 310.32
Dividend (Yield %) 3.00648
Beta 1.41
Next Earnings Date Feb 7, 2024

All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Mar 28, 2024 4451.6 21.2 0.48% 4430.4 4506.8 4405.4
Mar 27, 2024 4520.0 68.8 1.55% 4451.2 4555.1 4428.3
Mar 26, 2024 4434.4 14.0 0.32% 4420.4 4464.1 4412.3
Mar 25, 2024 4432.3 -60.7 -1.35% 4493.0 4524.2 4427.3
Mar 22, 2024 4522.0 11.9 0.26% 4510.1 4583.0 4510.1
Mar 21, 2024 4523.2 -4.9 -0.11% 4528.1 4548.3 4490.1
Mar 19, 2024 4521.2 84.8 1.91% 4436.4 4535.1 4416.3
Mar 18, 2024 4377.6 69.9 1.62% 4307.7 4395.9 4304.6
Mar 15, 2024 4244.9 3.1 0.07% 4241.8 4278.7 4211.9
Mar 14, 2024 4241.1 37.1 0.88% 4204.0 4271.9 4167.0
Mar 13, 2024 4166.0 -46.0 -1.09% 4212.0 4219.0 4129.1
Mar 12, 2024 4163.1 81.9 2.01% 4081.2 4163.1 4048.3
Mar 11, 2024 4144.2 -56.7 -1.35% 4200.9 4222.3 4097.2
Mar 8, 2024 4254.1 13.0 0.31% 4241.1 4280.0 4220.9
Mar 7, 2024 4188.0 -73.7 -1.73% 4261.7 4265.3 4176.0
Mar 6, 2024 4236.9 56.4 1.35% 4180.5 4246.2 4180.5
Mar 5, 2024 4165.1 -43.2 -1.03% 4208.3 4208.3 4158.0
Mar 4, 2024 4248.3 -5.7 -0.13% 4254.0 4294.6 4242.8
Mar 1, 2024 4268.8 78.6 1.88% 4190.2 4288.7 4184.9
Feb 29, 2024 4148.1 29.8 0.72% 4118.3 4166.0 4074.2

Mitsui Chemicals, Inc. Events

Time (UTC) Country Event
Friday, May 10, 2024

Time (UTC)

04:00

Country

JP

Event

Full Year 2024 Mitsui Chemicals Inc Earnings Release
Full Year 2024 Mitsui Chemicals Inc Earnings Release

Forecast

-

Previous

-
Wednesday, June 26, 2024

Time (UTC)

01:00

Country

JP

Event

Mitsui Chemicals Inc Annual Shareholders Meeting
Mitsui Chemicals Inc Annual Shareholders Meeting

Forecast

-

Previous

-
View all events
  • Annual
  • Quarterly
2023 2022 2021 2020 2019
Total revenue 1879550 1612690 1211720 1349520 1482910
Revenue 1879550 1612690 1211720 1349520 1482910
Cost of Revenue, Total 1498050 1233950 917883 1051140 1166580
Gross Profit 381493 378740 293842 298383 316332
Total Operating Expense 1750550 1465380 1133650 1284950 1387220
Selling/General/Admin. Expenses, Total 284589 239356 211980 226592 187109
Research & Development 35796
Unusual Expense (Income) -11656 12124 9596 6819 -2267
Operating Income 128998 147310 78074 64569 95694
Interest Income (Expense), Net Non-Operating -1068 -1626 -2659 -876 13426
Gain (Loss) on Sale of Assets -3605
Other, Net -10652 -4410 -1172 -2869 -218
Net Income Before Taxes 117278 141274 74243 60824 105297
Net Income After Taxes 90138 118551 64219 42619 86523
Minority Interest -7202 -8561 -6346 -8649 -10408
Net Income Before Extra. Items 82936 109990 57873 33970 76115
Net Income 82936 109990 57873 33970 76115
Income Available to Common Excl. Extra. Items 82936 109990 57873 33970 76115
Income Available to Common Incl. Extra. Items 82936 109990 57873 33970 76115
Diluted Net Income 82936 109990 57873 33970 76115
Diluted Weighted Average Shares 192.35 194.517 194.202 194.649 197.394
Diluted EPS Excluding Extraordinary Items 431.173 565.453 298.004 174.52 385.599
Dividends per Share - Common Stock Primary Issue 120 115 100 100 100
Diluted Normalized EPS 384.598 617.757 340.745 199.067 394.467
Interest Expense (Income) - Net Operating -21693 -25819 -5989 -4512
Other Operating Expenses, Total 1255 5769 181 4915
Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
Total revenue 450636 477834 474964 476113 447609
Revenue 450636 477834 474964 476113 447609
Cost of Revenue, Total 372988 377617 375923 371526 352337
Gross Profit 77648 100217 99041 104587 95272
Total Operating Expense 428656 443324 445405 433164 436325
Selling/General/Admin. Expenses, Total 75357 70624 70100 68508 70185
Interest Expense (Income) - Net Operating -3246 -4259 -5178 -9010 -3835
Unusual Expense (Income) -18067 -483 4652 2242 17138
Other Operating Expenses, Total 1624 -175 -92 -102 500
Operating Income 21980 34510 29559 42949 11284
Interest Income (Expense), Net Non-Operating -4889 -4977 276 -2130 411
Other, Net
Net Income Before Taxes 17091 29533 29835 40819 11695
Net Income After Taxes 18501 23061 18625 29951 11034
Minority Interest -511 -2468 -2264 -1959 -1111
Net Income Before Extra. Items 17990 20593 16361 27992 9923
Net Income 17990 20593 16361 27992 9923
Income Available to Common Excl. Extra. Items 17990 20593 16361 27992 9923
Income Available to Common Incl. Extra. Items 17990 20593 16361 27992 9923
Diluted Net Income 17990 20593 16361 27992 9923
Diluted Weighted Average Shares 190.264 192.555 193.344 193.235 193.236
Diluted EPS Excluding Extraordinary Items 94.5529 106.946 84.621 144.86 51.3516
Dividends per Share - Common Stock Primary Issue 60 0 60 0 60
Diluted Normalized EPS 32.8305 104.987 99.6413 153.373 135.028
  • Annual
  • Quarterly
2023 2022 2021 2020 2019
Total Current Assets 1094290 1033440 787572 781834 786677
Cash and Short Term Investments 262719 224648 223163 201376 111056
Cash & Equivalents 185377 179754 193585 163983 111056
Total Receivables, Net 376356 386352 290938 284992 365161
Accounts Receivable - Trade, Net 339843 357221 274902 261497 309873
Total Inventory 441949 369009 258814 284306 301890
Other Current Assets, Total 6988 47479 9616 6765 8570
Total Assets 2068200 1934960 1558120 1530520 1501070
Property/Plant/Equipment, Total - Net 600887 553584 501960 499650 443063
Property/Plant/Equipment, Total - Gross 2030730 1985550 1836070 1799940 1637100
Accumulated Depreciation, Total -1429840 -1431970 -1334110 -1300290 -1194030
Goodwill, Net 19338 17981 1123 1476 5061
Intangibles, Net 48137 45341 19678 24759 24324
Long Term Investments 229123 210460 178194 173752 165199
Other Long Term Assets, Total 76432 74154 69598 49044 76750
Total Current Liabilities 695444 706569 466305 485674 458758
Accounts Payable 161197 173032 117750 117920 163908
Accrued Expenses 175
Notes Payable/Short Term Debt 324120 297437 162182 179829 102733
Current Port. of LT Debt/Capital Leases 44343 49178 54539 52964 57997
Other Current Liabilities, Total 165784 186922 131834 134961 133945
Total Liabilities 1281380 1222310 950204 1001300 949159
Total Long Term Debt 369786 319471 293495 313237 321288
Long Term Debt 369786 319471 293495 313237 321288
Deferred Income Tax 35162 28133 27834 23017 11471
Minority Interest 96476 94468 74236 80487 79824
Other Liabilities, Total 84508 73670 88334 98880 77818
Total Equity 786827 712654 607921 529220 551915
Common Stock 125572 125414 125331 125298 125205
Additional Paid-In Capital 57778 69866 74009 79320 89406
Retained Earnings (Accumulated Deficit) 575125 516098 424084 359794 348202
Treasury Stock - Common -32704 -34932 -24900 -39254 -29869
Unrealized Gain (Loss) 21421
Other Equity, Total 61056 36208 9397 4062 -2450
Total Liabilities & Shareholders’ Equity 2068200 1934960 1558120 1530520 1501070
Total Common Shares Outstanding 190.066 193.236 195.944 191.051 195.057
Short Term Investments 77342 44894 29578 37393
Prepaid Expenses 6274 5957 5041 4395
Sep 2023 Jun 2023 Mar 2023 Dec 2022 Sep 2022
Total Current Assets 1082520 1078870 1094290 1132300 1131380
Cash and Short Term Investments 244019 212227 262719 234673 253049
Cash & Equivalents 202563 169048 186310 193408 208260
Short Term Investments 41456 43179 76409 41265 44789
Total Receivables, Net 319387 318876 352181 379530 370019
Accounts Receivable - Trade, Net 319387 318876 352181 379530 370019
Total Inventory 441036 449087 441949 455309 451270
Other Current Assets, Total 78081 98678 37437 62787 57042
Total Assets 2104350 2062840 2068200 2085710 2080210
Property/Plant/Equipment, Total - Net 625412 598893 600887 593483 585115
Goodwill, Net 20877 19524 19338 19636 18130
Intangibles, Net 53152 50098 48137 46683 45589
Long Term Investments 239111 231808 229123 226398 237177
Other Long Term Assets, Total 83278 83646 76432 67207 62821
Total Current Liabilities 681494 675043 695444 754833 744574
Accounts Payable 154355 137705 164267 186395 188866
Notes Payable/Short Term Debt 0 0 324120 0 0
Current Port. of LT Debt/Capital Leases 345355 371754 44343 400938 368079
Other Current Liabilities, Total 181784 165584 162714 167500 187629
Total Liabilities 1273040 1253500 1281380 1320000 1303940
Total Long Term Debt 372342 362959 369786 353735 346469
Long Term Debt 372342 362959 369786 353735 346469
Deferred Income Tax 41541 39260 35162 30204 29416
Minority Interest 98338 98278 96476 97079 97205
Other Liabilities, Total 79330 77964 84508 84144 86281
Total Equity 831308 809333 786827 765711 776267
Common Stock 125738 125572 125572 125572 125572
Additional Paid-In Capital 57945 57778 57778 57778 70024
Retained Earnings (Accumulated Deficit) 588256 577386 575125 549631 537654
Treasury Stock - Common -32723 -32713 -32704 -27679 -34938
Other Equity, Total 92092 81310 61056 44857 61797
Total Liabilities & Shareholders’ Equity 2104350 2062840 2068200 2085710 2080210
Total Common Shares Outstanding 190.141 190.064 190.066 191.722 193.344
Unrealized Gain (Loss) 15552 16158
  • Annual
  • Quarterly
2023 2022 2021 2020 2019
Net income/Starting Line 117278 141274 74243 60824 105297
Cash From Operating Activities 101241 92584 174323 142232 109492
Cash From Operating Activities 92080 84222 76621 76009 48853
Amortization 651
Non-Cash Items -15519 -16634 2782 -2582 -23624
Cash Taxes Paid 34394 17036 7764 19212 17124
Cash Interest Paid 5889 3972 4705 5589 5507
Changes in Working Capital -92598 -116278 20677 7981 -21685
Cash From Investing Activities -106340 -205234 -77555 -109112 -64255
Capital Expenditures -137861 -116216 -76581 -99771 -55755
Other Investing Cash Flow Items, Total 31521 -89018 -974 -9341 -8500
Cash From Financing Activities 2542 89222 -68956 -6365 -14134
Financing Cash Flow Items -22842 -14873 -3466 -6700 -6118
Total Cash Dividends Paid -24161 -20527 -19349 -19509 -18878
Issuance (Retirement) of Stock, Net -10018 -10031 -688 -9369 -10028
Issuance (Retirement) of Debt, Net 59563 134653 -45453 29213 20890
Foreign Exchange Effects 7715 8593 3604 -1673 -92
Net Change in Cash 5158 -14835 31416 25082 31011
Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
Net income/Starting Line 117278 100187 70654 40819 141274
Cash From Operating Activities 101241 44084 21911 -10642 92584
Cash From Operating Activities 92080 68800 44945 21842 84222
Non-Cash Items -15519 -12867 -9532 -7036 -16634
Cash Taxes Paid 34394 34478 21686 14051 17036
Cash Interest Paid 5889 4157 2395 1121 3972
Changes in Working Capital -92598 -112036 -84156 -66267 -116278
Cash From Investing Activities -106340 -67306 -14042 -33248 -205234
Capital Expenditures -137861 -100127 -50628 -32401 -116216
Other Investing Cash Flow Items, Total 31521 32821 36586 -847 -89018
Cash From Financing Activities 2542 29019 5508 44419 89222
Financing Cash Flow Items -22842 -19782 -19304 -3902 -14873
Total Cash Dividends Paid -24161 -24161 -12560 -12560 -20527
Issuance (Retirement) of Stock, Net -10018 -4993 -6 -3 -10031
Issuance (Retirement) of Debt, Net 59563 77955 37378 60884 134653
Foreign Exchange Effects 7715 6459 13731 9187 8593
Net Change in Cash 5158 12256 27108 9716 -14835

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
Leverage
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

Mitsui Chemicals, Inc. Company profile

About Mitsui Chemicals, Inc.

Mitsui Chemicals, Inc. is a chemical manufacturer mainly engaged in the manufacture and sale of mobility, healthcare, food & packaging and basic materials. The Company operates in four business segments. The Mobility segment is engaged in the manufacture and sale of elastomers, functional compounds, functional polymers and polypropylene compounds. The Healthcare segment is engaged in the manufacture and sale of vision care materials, nonwoven fabrics, dental materials and personal care materials. The Food & Packaging segment is engaged in the manufacture and sale of coatings and functional materials, functional films, sheets and pesticides. The Basic Material segment is engaged in the manufacture and sale of petrochemical raw materials such as ethylene and propylene, polyethylene, catalyst, phenol, high purity terephthalic acid, pet resin, polyurethane material and industrial chemicals.

Financial summary

BRIEF: For the nine months ended 31 December 2021, Mitsui Chemicals, Inc. revenues increased 36% to Y1.165T. Net income increased from Y33B to Y100.07B. Revenues reflect Mobility segment increase of 34% to Y296.95B, Food & Packing business segment increase of 19% to Y165.79B. Net income benefited from Equity in Loss of Affiliates increase from Y950M to Y21.98B (income), Other Operating Income increase of 85% to Y2.2B (income).

Equity composition

FY'94-02, FY'04-'06 1&3Q WAS & O/S were estimated. An increase in o/s in FY'98 due to the merger. FY'08 1Q & 3Q WAS was estimated and used for O/S.

Industry: Commodity Chemicals (NEC)

東京ミッドタウン八重洲 八重洲セントラルタワー
八重洲2-2-1
CHUO-KU
TOKYO-TO 104-0028
JP

Income Statement

  • Annual
  • Quarterly

News

A way forward: a roundup of recent central bank decisions

Five of the world’s most significant central banks delivered policy this week. We review the decisions and discuss their impact on the markets.

12:47, 22 March 2024

Bank of Japan Preview: will the BOJ end negative interest rates?

The Bank of Japan meets on Tuesday 19th of March. We preview what to expect from the BOJ decision and how it might impact the USD/JPY and Nikkei 225.

08:44, 18 March 2024

Higher CPI leaves traders unfazed as US equities continue to build momentum

The latest US CPI reading hasn’t gone how the Federal would have hoped. Consumer prices came in higher than expected in February for the third month in a row.

12:42, 15 March 2024

Four reasons why Bitcoin is surging to record highs

Bitcoin has surged to record highs. We discuss the four factors pushing Bitcoin higher and analyse the technicals of the cryptocurrency’s technicals.

10:18, 14 March 2024

China’s National People’s Congress: The markets have again been left wanting more

China’s National People’s Congress (NPC) is underway, and the markets have so far been disappointed by what’s been delivered by the country’s central government. We look at some of the significant takeaways from the event, discuss China’s current economic conditions, and analyse the China A50.

08:23, 8 March 2024
Facade on the Federal Reserve Building in Washington DC

Central Banks: which one will cut first?

Central banks dominate the calendar in March and markets try to anticipate which one will be the first one to cut

13:14, 6 March 2024

Nvidia (NVDA) confronts high expectations for Q4 results

Nvidia is arguably the hottest company on the planet. The company reports its Q4 results after the closing bell on Wednesday, the 21st of February. We preview what to expect from Nvidia’s earnings and analyse the technicals of its stock price.

12:13, 20 February 2024

People also watch

US100

18,285.60 Price
+0.020% 1D Chg, %
Long position overnight fee -0.0262%
Short position overnight fee 0.0040%
Overnight fee time 21:00 (UTC)
Spread 1.8

ETH/USD

3,587.18 Price
+1.830% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 21:00 (UTC)
Spread 6.00

BTC/USD

71,324.90 Price
+3.250% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 21:00 (UTC)
Spread 106.00

XRP/USD

0.63 Price
+1.510% 1D Chg, %
Long position overnight fee -0.0753%
Short position overnight fee 0.0069%
Overnight fee time 21:00 (UTC)
Spread 0.01168

Still looking for a broker you can trust?

Join the 580.000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading